What happened, in summary

This patient had regular breast screening every year, alternating mammography and ultrasound. One screening found a 1.5 cm breast tumor. She had not thought of herself as high risk: she exercised, felt healthy, and did not match the common risk factors she knew about. Testing showed hormone receptor-positive, HER2-positive breast cancer, and lymph nodes were not involved. Her initial treatment followed a standard curative plan: chemotherapy before surgery, surgery, chemotherapy after surgery, radiation therapy, molecular targeted therapy, and then hormone therapy taken seriously every day for 5 years to prevent recurrence. Because the cancer was found early and the lymph nodes were clear, she believed there was little left to worry about. Years later, a chest X-ray done as part of a health check found that the cancer had spread to her lungs. She did not yet have symptoms from the lung metastasis, but the diagnosis changed her life again. She began molecular targeted therapy and understood that the treatment might need to continue for the rest of her life. Facing that uncertainty and the financial burden of ongoing care, she started organizing practical matters while trying to enjoy the life remaining to her.